Szpital Specjalistyczny
Chojnice, Pomeranian, 89-600, Poland
NCT Number: NCT05982366
The distal transradial approach (dTRA) via the anatomical snuffbox is hypothesized to be more beneficial than the conventional transradial access (cTRA) in patients undergoing coronary procedures. This prospective single-center randomized trial was designed to investigate the safety, efficacy, and various ultrasound parameters of dTRA.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chojnice, Pomeranian, 89-600, Poland
Transradial approach (TRA) has emerged in most countries as a default strategy in urgent and elective coronary procedures. The advantages of TRA compared to the transfemoral access encompass a reduction of mortality, complications, and cost as well as improvement of patient's comfort. The aim of the present study (ANTARES, distAl vs coNventional Transradial Access for coRonary procEdures Study) was to assess the feasibility, safety and various ultrasound parameters of dTRA in the anatomical snuffbox as the first-line strategy, in comparison with cTRA, in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). The study is a non-inferiority, randomized controlled trial. There are two arms: distal transradial access and conventional transradial approach.
400 patients were enrolled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
coronary procedure (coronary angiography and/or coronary angioplasty) by the distal radial artery in the anatomical snuffbox area
Other names: dTRA
coronary procedure (coronary angiography and/or coronary angioplasty) by the forearm radial artery in the anatomical snuffbox area
Other names: cTRA
Time frame: up to 24 hours
Access crossover from unsuccessful random arterial access (if the initial access point fails) to another one.
Access-related complications after the procedure measured with Doppler Ultrasound (included radial artery occlusion, significant hematoma (EASY classification grade III-V), arteriovenous fistula, pseudoaneurysm, perforation and spasm).
MACE definied as myocardial infarction, stroke, urgent revascularization, all-cause death.
Time frame: during the procedure index
Access crossover from unsuccessful random arterial access (if the initial access point fails) to another one.
Time frame: during the procedure
physical discomfort at the time of vascular access performance was assessed using a numerical scale (0/1/2/3 - respectively no/mild/moderate/severe discomfort)
Time frame: during the procedure index
(measured from the time of skin puncture with local anesthetic to the successful sheath insertion confirmed by an outflow of arterial blood)
Time frame: after 24 hours post procedure
it is composed by the rate of radial artery occlusion, significant hematoma (EASY classification grade III-V), arteriovenous fistula, pseudoaneurysm, perforation and spasm; measured with Doppler Ultrasound
Time frame: during procedure
counted from local anesthesia to successful insertion of the sheath
Time frame: before the procedure, 24 hours and 60 days after the procedure
parameter measured by Doppler Ultrasound at the access point
Time frame: before the procedure, 24 hours and 60 days after the procedure
parameter measured by Doppler Ultrasound at the access point
Łukasz Koziński
Other
distAl vs. coNventional Transradial Access for coRonary procEdures Study (ANTARES)
Acronym: ANTARES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03986151
Arterial Occlusive Diseases, Arteriosclerosis
Pátrai, Achaia, Greece
View Trial DetailsNCT03393052
Arterial Occlusive Diseases, Arteriosclerosis
Pátrai, Achaia, Greece
View Trial DetailsNCT05911451
Arteriovenous Fistula, Arteriovenous Graft
Alkmaar, Netherlands
View Trial DetailsNCT05741866
Cardiovascular Diseases, Catheter Complications
Herston, Queensland, Australia
View Trial Details